BIOQUÍMICA Y FISIOLOGÍA HUMANA: Artículos de Revisión - Un Enfoque Pre-Clínico. EDICIÓN 2

22. Oscar Ruiz, D. D. (2003). Anemia carencial y
SIDA. Anales de la Facultad de Medicina
Universidad Nacional Mayor de San Marcos, 233-
238.
23. Palacios, J. R. (2007). SISTEMA INMUNE Y
LA SANGRE. Obtenido de infermeravirtual.com:
https://www.infermeravirtual.com/files/media/file/10
2/Sangre.pdf?1358605574
24. Petek Eylul Taneri, S. A.-O.-D.-H. (20 de agosto
de 2020). Anemia and iron metabolism in COVID-
19: a systematic review and meta-analysis. European
Journal of Epidemiology, 763-773.
doi:https://doi.org/10.1007/s10654-020-00678-5
25. Peter Sudbery, 2004, Genética Molecular
Humana, 2ª edición, Pearson
26. Qin C, Z. L. (2020). Dysregulation of immune
response in patients with COVID-19 in Wuhan,
China. J Chem Inf Model. doi:doi:
10.1093/cid/ciaa248
27. Richardson S, H. J. (2020). Presenting
characteristics, comorbidities, and outcomes among
5700 patients hospitalized with COVID-19 in the
New York City Area. JAMA.
Ruiz O, D. D. (2003). Anemia carencial y SIDA. An
Facultad Med., 233.
28. Saif, M. (2001). HIV-Associated autoimmune
hemolytic anemia: An update. Aids Patient Care.,
217-224.
29. Sarzi-Puttini P, G. V. (2020). COVID-19,
cytokines and immunosuppression: what can we
learn from severe acute respiratory syndrome?. Clin
Exp Rheumatol., 337-342.
30. Shi Y, W. Y. (2020). COVID-19 infection: the
perspectives on immune responses. Cell Death
Differ. doi:10.1038/s41418-020-0530-3
Spivak JL, B. D. (1989). Serum immunoreactive
erythropoietin in HIV-infected patients . JAMA, 261.
31. Spivak JL, B. D. (1989). Serum immunoreactive
erythropoietin in HIV-infected patients . JAMA, 261.
32. Stephanidou, C. (2020). Una contribución de la
federación international de Talasemia a su
comunidad global de pacientes. Thalassaemia
International federation, 6-7.
33. Vargas, M. d. (2020). Generalidades de anemias.
Revisión bibliográfica. Ocronos. Obtenido de
https://revistamedica.com/generalidades-anemiasrevision-bibliografica/
34. Wang L, H. W. (2020). Coronavirus disease 2019
in elderly patients: Characteristics and prognostic
factors based on 4-week follow-up. J Infect, 639-645.
35. Wessling-Resnick, M. (2018). Crossing the iron
gate: why and how transferrin receptors mediate viral
entry. Annu Rev Nutr, 431–458.
36. Wu D, Y. X. (2020). TH17 Responses in
Cytokine Storm of COVID-19: An Emerging Target
of JAK2 Inhibitor Fedratinib. J Microbiol Immunol
Infect. doi:10.1016/j.jmii.2020.03.005
37. Xiong Y, L. Y. (2020). Transcriptomic
Characteristics of Bronchoalveolar Lavage Fluid and
Peripheral Blood Mononuclear Cells in COVID-19
Patients. Emerg Microbes Infect, 761-770.
doi:10.1080/22221751.2020.1747363
38. Zauli G, R. M. (1992). Evidence for a human
immunodeficiency virus type-1 mediated suppression
of uninfected hematopoietic (CD34+) cells in AIDS
patients. . J Infect Dis, 710.
39. Zegarra-Valdivia J., V. V. (2020). Niveles de
Hemoglobina y Anemia en Niños: Implicancias Para
el Desarrollo de Las Funciones Ejecutivas. . Revista
Ecuatoriana de Neurología, 29.
40. Zhou F, Y. T. (2020). Clinical course and risk
factors for mortality of adult inpatients with COVID-
19 in Wuhan. Lancet, 1054-162.
59